Rogliani Paola (Paola Rogliani)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 139

Top Venues

Expert review of respiratory medicine

Expert opinion on pharmacotherapy

The European respiratory journal

Journal of clinical medicine

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

Italy

professore associato :: dipartimento di Medicina dei Sistemi

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

Italy

Ricercatore :: Dipartimento di Medicina Interna

Publications

Paolo Cameli, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Maria D'Amato, Fausto De Michele, Stefano Del Giacco, Federico Raimondi, Girolamo Pelaia, Rogliani Paola, Micaela Romagnoli, Pietro Schino, Jan Walter Schroeder, Gianenrico Senna, Alessandra Vultaggio, Marco Benci, Silvia Boarino, Francesco Menzella
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study. Journal of asthma and allergy 17 (2024)
Luigino Calzetta, Nicola Di Daniele, Alfredo Chetta, Marco Vitale, Shima Gholamalishahi, Mario Cazzola, Rogliani Paola
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement. Journal of clinical medicine 13 (4) (2024)
Pierachille Santus, Federico Raimondi, Matteo Bonini, Marco Contoli, Angelo Guido Corsico, Claudio Micheletto, Girolamo Pelaia, Dejan Radovanovic, Rogliani Paola, Laura Saderi, Nicola Scichilone, Silvia Tanzi, Manlio Vella, Silvia Boarino, Giovanni Sotgiu, Paolo Solidoro
Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study. International journal of chronic obstructive pulmonary disease 19 (2024)
Rossella Laitano, Luigino Calzetta, Matteo Matino, Elena Pistocchini, Rogliani Paola
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement. Expert opinion on pharmacotherapy (2024)
Josuel Ora, Rogliani Paola
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutions. The European respiratory journal 63 (1) (2024)
Luigino Calzetta, Rogliani Paola
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease. Expert review of respiratory medicine (2024)
Josuel Ora, Rogliani Paola
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutions. The European respiratory journal 63 (1) (2024)
Mario Cazzola, Josuel Ora, Mauro Maniscalco, Rogliani Paola
A clinician's guide to single vs multiple inhaler therapy for COPD. Expert review of respiratory medicine 18 (7) (2024)
Rogliani Paola, Gian Marco Manzetti, Federica Roberta Bettin, Maria D'Auria, Luigino Calzetta
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review. Expert opinion on investigational drugs (2024)
Luigino Calzetta, Rogliani Paola
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease. Expert review of respiratory medicine 17 (12) (2024)
Rossella Laitano, Luigino Calzetta, Matteo Matino, Elena Pistocchini, Rogliani Paola
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement. Expert opinion on pharmacotherapy (2024)
Josuel Ora, Patrizia De Marco, Mariachiara Gabriele, Mario Cazzola, Rogliani Paola
Exercise-Induced Asthma: Managing Respiratory Issues in Athletes. Journal of functional morphology and kinesiology 9 (1) (2024)
Rogliani Paola, Gian Marco Manzetti, Federica Roberta Bettin, Maria D'Auria, Luigino Calzetta
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review. Expert opinion on investigational drugs 33 (1) (2024)
Rogliani Paola, Gian Marco Manzetti, Federica Roberta Bettin, Maria D'Auria, Luigino Calzetta
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review. Expert opinion on investigational drugs 33 (1) (2024)
Luigino Calzetta, Rogliani Paola
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease. Expert review of respiratory medicine (2024)
Josuel Ora, Federica Maria Giorgino, Federica Roberta Bettin, Mariachiara Gabriele, Rogliani Paola
Pulmonary Function Tests: Easy Interpretation in Three Steps. Journal of clinical medicine 13 (13) (2024)
Josuel Ora, Patrizia De Marco, Mariachiara Gabriele, Mario Cazzola, Rogliani Paola
Exercise-Induced Asthma: Managing Respiratory Issues in Athletes. Journal of functional morphology and kinesiology 9 (1) (2024)
Mario Cazzola, Daiana Stolz, Mona Bafadhel, Rogliani Paola
Understanding evidence from randomised controlled trials and meta-analyses: a comparative overview. The European respiratory journal 63 (5) (2024)
Mario Cazzola, Josuel Ora, Mauro Maniscalco, Rogliani Paola
A clinician's guide to single vs multiple inhaler therapy for COPD. Expert review of respiratory medicine (2024)
Rogliani Paola, Gian Marco Manzetti, Federica Roberta Bettin, Maria D'Auria, Luigino Calzetta
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review. Expert opinion on investigational drugs (2024)
Rossella Laitano, Luigino Calzetta, Matteo Matino, Elena Pistocchini, Rogliani Paola
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement. Expert opinion on pharmacotherapy 25 (8) (2024)
Paolo Cameli, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Maria D'Amato, Fausto De Michele, Stefano Del Giacco, Federico Raimondi, Girolamo Pelaia, Rogliani Paola, Micaela Romagnoli, Pietro Schino, Jan Walter Schroeder, Gianenrico Senna, Alessandra Vultaggio, Marco Benci, Silvia Boarino, Francesco Menzella
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study. Journal of asthma and allergy 17 (2024)
Luigino Calzetta, Nicola Di Daniele, Alfredo Chetta, Marco Vitale, Shima Gholamalishahi, Mario Cazzola, Rogliani Paola
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement. Journal of clinical medicine 13 (4) (2024)
Mario Cazzola, Josuel Ora, Mauro Maniscalco, Rogliani Paola
A clinician's guide to single vs multiple inhaler therapy for COPD. Expert review of respiratory medicine (2024)
Josuel Ora, Rogliani Paola
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutions. The European respiratory journal 63 (1) (2024)
Josuel Ora, Rogliani Paola
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutions. The European respiratory journal 63 (1) (2024)
Luigino Calzetta, Rogliani Paola
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease. Expert review of respiratory medicine 17 (12) (2024)
Josuel Ora, Rogliani Paola
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutions. The European respiratory journal 63 (1) (2024)
Josuel Ora, Patrizia De Marco, Mariachiara Gabriele, Mario Cazzola, Rogliani Paola
Exercise-Induced Asthma: Managing Respiratory Issues in Athletes. Journal of functional morphology and kinesiology 9 (1) (2024)
Josuel Ora, Rogliani Paola
Clinical Challenges in Applying the New Lung Function Tests Interpretive Strategies: Navigating Pitfalls and Possible Solutions. The European respiratory journal (2024)
Pierachille Santus, Federico Raimondi, Matteo Bonini, Marco Contoli, Angelo Guido Corsico, Claudio Micheletto, Girolamo Pelaia, Dejan Radovanovic, Rogliani Paola, Laura Saderi, Nicola Scichilone, Silvia Tanzi, Manlio Vella, Silvia Boarino, Giovanni Sotgiu, Paolo Solidoro
Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study. International journal of chronic obstructive pulmonary disease 19 (2024)
Josuel Ora, Federica Maria Giorgino, Federica Roberta Bettin, Mariachiara Gabriele, Rogliani Paola
Pulmonary Function Tests: Easy Interpretation in Three Steps. Journal of clinical medicine 13 (13) (2024)
Mario Cazzola, Rogliani Paola, Josuel Ora, Luigino Calzetta, Davide Lauro, Maria Gabriella Matera
Hyperglycaemia and Chronic Obstructive Pulmonary Disease. Diagnostics (Basel, Switzerland) 13 (21) (2023)
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, Rogliani Paola, Mario Cazzola
Investigational anti IL-13 asthma treatments: a 2023 update. Expert opinion on investigational drugs (2023)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Annalisa Frizzelli, Josuel Ora, Enrico Melis, Francesco Facciolo, Lorenzo Ippoliti, Andrea Magrini, Rogliani Paola
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines 11 (2) (2023)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Annalisa Frizzelli, Josuel Ora, Enrico Melis, Francesco Facciolo, Lorenzo Ippoliti, Andrea Magrini, Rogliani Paola
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines 11 (2) (2023)
Josuel Ora, Luigino Calzetta, Chiara Frugoni, Ermanno Puxeddu, Rogliani Paola
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert opinion on pharmacotherapy 24 (3) (2023)
Daiana Stolz, Maria Gabriella Matera, Rogliani Paola, Maarten van den Berge, Eleni Papakonstantinou, Reinoud Gosens, Dave Singh, Nicola Hanania, Mario Cazzola, Anke-Hilse Maitland-van der Zee, Laura Fregonese, Alexander G Mathioudakis, Jorgen Vestbo, Maia Rukhadze, Clive P Page
Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022. Breathe (Sheffield, England) 19 (2) (2023)
Rogliani Paola, Rossella Laitano, Josuel Ora, Richard Beasley, Luigino Calzetta
Strength of association between comorbidities and asthma: a meta-analysis. European respiratory review : an official journal of the European Respiratory Society 32 (167) (2023)
Mario Cazzola, Clive P Page, Maria Gabriella Matera, Rogliani Paola, Nicola A Hanania
Revisiting Asthma Pharmacotherapy: Where Do We Stand and Where Do We Want to Go? The European respiratory journal (2023)
Josuel Ora, Luigino Calzetta, Chiara Frugoni, Ermanno Puxeddu, Rogliani Paola
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert opinion on pharmacotherapy 24 (3) (2023)
Rogliani Paola, Rossella Laitano, Josuel Ora, Richard Beasley, Luigino Calzetta
Strength of association between comorbidities and asthma: a meta-analysis. European respiratory review : an official journal of the European Respiratory Society 32 (167) (2023)
Josuel Ora, Luigino Calzetta, Chiara Frugoni, Ermanno Puxeddu, Rogliani Paola
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert opinion on pharmacotherapy (2023)
Luigino Calzetta, Clive Page, Maria Gabriella Matera, Mario Cazzola, Rogliani Paola
Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders. British journal of pharmacology (2023)
Maria Gabriella Matera, Josuel Ora, Rogliani Paola, Mario Cazzola
An overview of the preclinical discovery and development of tezepelumab for the treatment of asthma. Expert opinion on drug discovery (2023)
Rogliani Paola, Rossella Laitano, Josuel Ora, Richard Beasley, Luigino Calzetta
Strength of association between comorbidities and asthma: a meta-analysis. European respiratory review : an official journal of the European Respiratory Society 32 (167) (2023)
Rossella Laitano, Luigino Calzetta, Francesco Cavalli, Mario Cazzola, Rogliani Paola
Delivering monoclonal antibodies via inhalation: A systematic review of clinical trials in asthma and COPD. Expert opinion on drug delivery (2023)
Daiana Stolz, Maria Gabriella Matera, Rogliani Paola, Maarten van den Berge, Eleni Papakonstantinou, Reinoud Gosens, Dave Singh, Nicola Hanania, Mario Cazzola, Anke-Hilse Maitland-van der Zee, Laura Fregonese, Alexander G Mathioudakis, Jorgen Vestbo, Maia Rukhadze, Clive P Page
Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022. Breathe (Sheffield, England) 19 (2) (2023)
Rogliani Paola, Rossella Laitano, Josuel Ora, Richard Beasley, Luigino Calzetta
Strength of association between comorbidities and asthma: a meta-analysis. European respiratory review : an official journal of the European Respiratory Society 32 (167) (2023)
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Rogliani Paola, Maria Gabriella Matera
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert review of respiratory medicine (2023)
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, Rogliani Paola, Mario Cazzola
Investigational anti IL-13 asthma treatments: a 2023 update. Expert opinion on investigational drugs (2023)
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Rogliani Paola, Maria Gabriella Matera
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert review of respiratory medicine 16 (11-12) (2023)
Mario Cazzola, Rogliani Paola, Francesco Blasi
Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD? International journal of chronic obstructive pulmonary disease 18 (2023)
Gian Marco Manzetti, Josuel Ora, Arianna Sepiacci, Mario Cazzola, Rogliani Paola, Luigino Calzetta
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement. International journal of chronic obstructive pulmonary disease 18 (2023)
Maria Gabriella Matera, Rogliani Paola, Giuseppe Novelli, Mario Cazzola
The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update. Expert opinion on drug metabolism & toxicology (2023)
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Rogliani Paola, Maria Gabriella Matera
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert review of respiratory medicine 16 (11-12) (2023)
Josuel Ora, Rogliani Paola, Federica Ferron, Marilisa Vignuoli, Letizia Valentino, Giancarlo Pontoni, Francesca Di Ciuccio, Roberto Ferrara, Tommaso Sciarra
Effects of SARS-CoV-2 on Pulmonary Function and Muscle Strength Testing in Military Subjects According to the Period of Infection: Cross-Sectional Study. Diagnostics (Basel, Switzerland) 13 (10) (2023)
Luigino Calzetta, Elena Pistocchini, Alfredo Chetta, Rogliani Paola, Mario Cazzola
Experimental drugs in clinical trials for COPD: Artificial Intelligence via Machine Learning approach to predict the successful advance from early-stage development to approval. Expert opinion on investigational drugs (2023)
Daiana Stolz, Maria Gabriella Matera, Rogliani Paola, Maarten van den Berge, Eleni Papakonstantinou, Reinoud Gosens, Dave Singh, Nicola Hanania, Mario Cazzola, Anke-Hilse Maitland-van der Zee, Laura Fregonese, Alexander G Mathioudakis, Jorgen Vestbo, Maia Rukhadze, Clive P Page
Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022. Breathe (Sheffield, England) 19 (2) (2023)
Maria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, Mario Cazzola, Rogliani Paola
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases. Expert opinion on drug delivery (2023)
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Rogliani Paola, Maria Gabriella Matera
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert review of respiratory medicine (2023)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy 23 (2) (2022)
Mohammad Alkhatib, Maria Concetta Bellocchi, Greta Marchegiani, Sandro Grelli, Valeria Micheli, Daniele Stella, Bartolomeo Zerillo, Luca Carioti, Valentina Svicher, Rogliani Paola, Francesca Ceccherini-Silberstein
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? Microorganisms 10 (2) (2022)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Francesca Camardelli, Mario Cazzola, Rogliani Paola, Alfredo Chetta
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis. Cells 11 (11) (2022)
Rogliani Paola, Clive Peter Page, Luigino Calzetta
Prescribing the right therapy for the treatment of chronic cough: a critical focus on current and investigational options. Expert opinion on pharmacotherapy 23 (7) (2022)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy 23 (2) (2022)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Elena Pistocchini, Rogliani Paola
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review. International journal of molecular sciences 23 (23) (2022)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Elena Pistocchini, Beatrice Ludovica Ritondo, Rogliani Paola, Alfredo Chetta
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma. Biomedicines 10 (9) (2022)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Elena Pistocchini, Rogliani Paola
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review. International journal of molecular sciences 23 (23) (2022)
Josuel Ora, Luigino Calzetta, Chiara Frugoni, Ermanno Puxeddu, Rogliani Paola
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert opinion on pharmacotherapy (2022)
Miguel Angel Martinez-Garcia, Fernando Santamaría-Martos, Alberto García-Ortega, Maria Gabriella Matera, Rogliani Paola, Mario Cazzola
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review. Drugs 82 (14) (2022)
Maria Gabriella Matera, Barbara Rinaldi, Vito de Novellis, Rogliani Paola, Mario Cazzola
Current and emerging treatment modalities for bacterial rhinosinusitis in adults: a comprehensive review. Expert opinion on pharmacotherapy 23 (18) (2022)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Cristina Zappa, Gian Marco Manzetti, Andrea Perduno, Janis Shute, Rogliani Paola
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review. European respiratory review : an official journal of the European Respiratory Society 31 (164) (2022)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy (2022)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Beatrice Ludovica Ritondo, Elena Pistocchini, Rogliani Paola, Alfredo Chetta
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis. Pharmaceutics 14 (8) (2022)
Mario Cazzola, Josuel Ora, Luigino Calzetta, Rogliani Paola, Maria Gabriella Matera
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? Expert opinion on pharmacotherapy 23 (8) (2022)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Elena Pistocchini, Rogliani Paola
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review. International journal of molecular sciences 23 (23) (2022)
Mario Cazzola, Clive Peter Page, Rogliani Paola, Luigino Calzetta, Maria Gabriella Matera
Dual bronchodilation for the treatment of COPD: From bench to bedside. British journal of clinical pharmacology 88 (8) (2022)
Mario Cazzola, Rogliani Paola, Silvio Naviglio, Luigino Calzetta, Maria Gabriella Matera
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma. Expert opinion on pharmacotherapy 23 (10) (2022)
Josuel Ora, Bartolomeo Zerillo, Patrizia De Marco, Gian Marco Manzetti, Ilaria De Guido, Luigino Calzetta, Rogliani Paola
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance. Journal of clinical medicine 11 (17) (2022)
Peter M A Calverley, Alberto Papi, Clive Peter Page, Rogliani Paola, Roberto Walter Dal Negro, Mario Cazzola, Arrigo Francesco Giuseppe Cicero, Jadwiga A Wedzicha
The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset. International journal of chronic obstructive pulmonary disease 17 (2022)
Gianenrico Senna, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Paolo Cameli, Giorgio Walter Canonica, Cristiano Caruso, Maria D'Amato, Fausto De Michele, Stefano Del Giacco, Federico Raimondi, Francesco Menzella, Girolamo Pelaia, Rogliani Paola, Micaela Romagnoli, Pietro Schino, Jan Walter Schroeder, Alessandra Vultaggio, Sara Rizzoli, Alessandro Zullo, Silvia Boarino, Marilena Palmisano, Alessandra Rossi, Gianfranco Vitiello, Stefano Centanni
Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm<sup>3</sup>: A Post Hoc Analysis from the ANANKE Study. Journal of asthma and allergy 15 (2022)
Mario Cazzola, Rogliani Paola, Luigino Calzetta, Josuel Ora, Maria Gabriella Matera
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD. Expert review of clinical pharmacology 15 (3) (2022)
Rogliani Paola, Josuel Ora, Francesco Cavalli, Mario Cazzola, Luigino Calzetta
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score. Journal of clinical medicine 11 (15) (2022)
Rogliani Paola, Francesco Cavalli, Alfredo Chetta, Mario Cazzola, Luigino Calzetta
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile. Journal of asthma and allergy 15 (2022)
Mario Cazzola, Rogliani Paola, Rossella Laitano, Luigino Calzetta, Maria Gabriella Matera
Beyond Dual Bronchodilation - Triple Therapy, When and Why. International journal of chronic obstructive pulmonary disease 17 (2022)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Elena Pistocchini, Rogliani Paola
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review. International journal of molecular sciences 23 (23) (2022)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy (2022)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy 23 (2) (2022)
Rogliani Paola, Luigino Calzetta
Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies. Journal of experimental pharmacology 14 (2022)
Maria Gabriella Matera, Luigino Calzetta, Josuel Ora, Rogliani Paola, Mario Cazzola
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs. Expert opinion on drug delivery 18 (7) (2021)
Maria Gabriella Matera, Josuel Ora, Francesco Cavalli, Rogliani Paola, Mario Cazzola
New Avenues for Phosphodiesterase Inhibitors in Asthma. Journal of experimental pharmacology 13 (2021)
Eugenio Pompeo, Ahmed G Elkhouly, Rogliani Paola, Mario Dauri, Michael Peer, Gianluigi Sergiacomi, Roberto Sorge
Quasilobar minimalist lung volume reduction surgery. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 60 (3) (2021)
Rogliani Paola, Luigino Calzetta
Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs. Expert opinion on pharmacotherapy 22 (7) (2021)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Giuseppina Bertorelli, Rogliani Paola, Alfredo Chetta
Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence. International journal of molecular sciences 22 (13) (2021)
Mario Cazzola, Josuel Ora, Francesco Cavalli, Rogliani Paola, Maria Gabriella Matera
An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease. Biologics : targets & therapy 15 (2021)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Alfredo Chetta, Rogliani Paola
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies. Expert review of respiratory medicine (2021)
Josuel Ora, Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Rogliani Paola
Current long-acting muscarinic antagonists for the treatment of asthma. Expert opinion on pharmacotherapy 22 (17) (2021)
Rogliani Paola, Luigino Calzetta
Mortality in ETHOS: A Question of "Power". American journal of respiratory and critical care medicine 203 (7) (2021)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Giuseppina Bertorelli, Beatrice Ludovica Ritondo, Rogliani Paola, Alfredo Chetta
The Impact of Monoclonal Antibodies on Airway Smooth Muscle Contractility in Asthma: A Systematic Review. Biomedicines 9 (9) (2021)

Rogliani Paola.css-eqlu8i{font-size:small;padding-left:4px;} (Paola Rogliani)

Publication Activity (10 Years)

Top Topics

Top Venues

Rogliani Paola (Paola Rogliani)